People who combine berberine with semaglutide or take other supplements alongside their GLP-1 therapy should be aware that stacking multiple blood-sugar-lowering compounds increases the risk of hypoglycemia
The most frequent adverse effects are gastrointestinal and dose-related: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort - Typically worst during dose escalation and often resolve or attenuate with continued treatment and slower titration
Understanding which medication carries which risk profile allows you to take targeted prevention measures rather than worrying about risks that do not actually apply to your semaglutide protocol
The reward is the same for every star rating and opinion
For example, if a phase I metabolite cant be cleared out quickly enough with phase II conjugation, then it can cause oxidative stress
Supports Weight Management*